CERo Therapeutics has initiated a Phase 1 clinical trial for its innovative product candidate, CER-1236, targeting acute myeloid leukemia, signifying a key milestone in its development pipeline.

Alt.Latino The global Latinx community is evolving and growing fast.Alt.Latino is here to celebrate it and all of its nuances through music. Each episode, NPR Music's Felix Contreras and Anamaria ...

ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer at Altimmune, will present body composition data from the Phase 2 MOMENTUM trial of ...

The erythrocyte sedimentation rate test observes how quickly red blood cells fall to the bottom of a test tube. During normal circumstances, these cells descend slowly through the plasma. However ...

What happens if the UEFA Europa League winners have already qualified for the 2025/26 UEFA Champions League via their domestic league position? Twenty-five teams will qualify automatically by ...

A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a ...

Phase 4 saw TV shows folded into the MCU's interconnected storylines more than ever before and this has continued throughout Phase 5 and the already-confirmed Phase 6, which will wrap up with an ...

The in vivo localization studies presented here show that CKGGRAKDC targets the white adipose vasculature without a detectable preference for any particular anatomical white fat depot. The uptake ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...

It is for this reason, under the 2024–27 club competition format, that if the Europa League winners have also qualified for the league phase of the Champions League via their domestic league ...

May 1, 2025 • Anamaria Sayre talks about the history of Puerto Rican hip-hop with rapper PJ Sin Suela.

A new study conducted in Italy reveals a reduction in long-COVID burden 7 months following the acute phase. The study, published in BMC Infectious Diseases, also shows that one-third of patients ...